Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies

References

• The Economist Intelligence UnitThe Future of Healthcare in Europe Available from: http://www.janssen.pt/sites/default/files/The-Future-Of-Healthcare-In-Europe.pdf2012Accessed August 1, 2015
   Google Scholar
• European CommissionThe 2015 Ageing Report Available from: http://ec.europa.eu/economy_finance/publications/european_economy/2014/pdf/ee8_en.pdf2015Accessed August 1, 2015
   Google Scholar
• StewartBWChristopherPWildCPWorld Cancer Report 2014IARC publication, distributed by WHO Press2014
   Google Scholar
• BregoliLMoviaDGavigan-ImedioJDLysaghtJReynoldsJPrina-MelloANanomedicine applied to translational oncology: a future perspective on cancer treatmentNanomedicine Epub 2015 Sep 11
   Web of Science ®Google Scholar
• Von HoffDDErvinTArenaFPIncreased survival in pancreatic cancer with nab-paclitaxel plus gemcitabineNew Engl J Med2013369181691170324131140
   PubMed Web of Science ®Google Scholar
• KimuraKTanakaSIwamotoMSafety of nanoparticle albumin-bound paclitaxel administered to breast cancer patients with clinical contraindications to paclitaxel or docetaxel: four case reportsOncol Lett20136488188424137430
   PubMed Web of Science ®Google Scholar
• MuddinetiOSGhoshBBiswasSCurrent trends in using polymer coated gold nanoparticles for cancer therapyInt J Pharm20154841–225226725701627
   PubMedGoogle Scholar
• PatraCRBhattacharyaRMukhopadhyayDMukherjeePFabrication of gold nanoparticles for targeted therapy in pancreatic cancerAdv Drug Deliv Rev201062334636119914317
   PubMed Web of Science ®Google Scholar
• Cythlmmune [webpage on the Internet]Aurimune: A nanomedicine platform Available from: http://www.cytimmune.com/Accessed August 2015
   Google Scholar
• LibuttiSKPaciottiGFByrnesAAPhase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rh TNF nanomedicineClin Cancer Res201016246139614920876255
   PubMed Web of Science ®Google Scholar
• LiSDHuangLPharmacokinetics and biodistribution of nanoparticlesMol Pharm20085449650418611037
   PubMed Web of Science ®Google Scholar
• GadSCSharpKLMontgomeryCPayneJDGoodrichGPEvaluation of the toxicity of intravenous delivery of auroshell particles (gold-silica nanoshells)Int J Toxicol201231658459423212452
   PubMed Web of Science ®Google Scholar
• SchwartzJAShettyAMPriceREFeasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine modelCancer Res20096941659166719208847
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov Available from: https://clinicaltrials.gov/Accessed August 2015
   Google Scholar
• Available from: http://www.cytimmune.com/#pipelineAccessed August 2015
   Google Scholar
• MoviaDGerardVMaguireCMA safe-by-design approach to the development of gold nanoboxes as carriers for internalization into cancer cellsBiomaterials20143592543255724429386
   PubMed Web of Science ®Google Scholar
• WeiGWangLSunLType I collagen-mediated synthesis and assembly of UV-photoreduced gold nanoparticles and their application in surface-enhanced Raman scatteringJ Phys Chem C2007111519761982
   Web of Science ®Google Scholar
• MoviaDPolandCTranLVolkovYPrina-MelloAMultilayered nanoparticles for personalized medicine: translation into clinical marketsBawaRAudetteGFRubinsteinIHandbook of Clinical Nanomedicine: Nanoparticles, Imaging, Therapy, and Clinical ApplicationsSingaporePan Stanford Publishing2015
   Google Scholar
• KudgusRAWaldenCAMcGovernRMReidJMRobertsonJDMukherjeePTuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting componentSci Rep20144566925011609
   PubMed Web of Science ®Google Scholar
• EckWCraigGSigdelAPEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissueACS Nano20082112263227219206392
   PubMed Web of Science ®Google Scholar
• ChenWAyala-OrozcoCBiswalNCTargeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshellsNanomedicine2014981209122224063415
   PubMed Web of Science ®Google Scholar
• CuiRLiuCShenJGaoDZhuJ-JChenH-YGold nanoparticle–colloidal carbon nanosphere hybrid material: preparation, characterization, and application for an amplified electrochemical immunoassayAdv Funct Mater2008181521972204
   Web of Science ®Google Scholar
• RazzakRZhouJYangXThe biodistribution and pharmacokinetic evaluation of choline-bound gold nanoparticles in a human prostate tumor xenograft modelClin Invest Med2013363E133E14223739667
   PubMed Web of Science ®Google Scholar
• YouJZhouJZhouMPharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheresPart Fibre Toxicol2014112624886070
   PubMed Web of Science ®Google Scholar
• RayDAswalVKKohlbrecherJSynthesis and characterization of high concentration block copolymer-mediated gold nanoparticlesLangmuir20112774048405621366279
   PubMed Web of Science ®Google Scholar
• ConnorEEMwamukaJGoleAMurphyCJWyattMDGold nanoparticles are taken up by human cells but do not cause acute cytotoxicitySmall20051332532717193451
   PubMed Web of Science ®Google Scholar
• LiCFanFYinBChenLGangulyTTianZAu+-cetyltrimethylammonium bromide solution: a novel precursor for seed-mediated growth of gold nanoparticles in aqueous solutionNano Res2013612937
   Web of Science ®Google Scholar
• Guerrero-MartínezAPérez-JusteJCarbó-ArgibayETardajosGLiz-MarzánLMGemini-surfactant-directed self-assembly of monodisperse gold nanorods into standing superlatticesAngew Chem Int Ed Engl200948509484948819802865
   PubMed Web of Science ®Google Scholar
• LiaoH-GJiangY-XZhouZ-YChenS-PSunS-GShape-controlled synthesis of gold nanoparticles in deep eutectic solvents for studies of structure–functionality relationships in electrocatalysisAngew Chem Int Ed Engl200847479100910318925592
   PubMed Web of Science ®Google Scholar
• SpadavecchiaJMoreauJHottinJCanvaMNew cysteamine based functionalization for biochip applicationsSensor Actuat B Chem20091431139143
   Web of Science ®Google Scholar
• LastraioliELottiniTBenciniLBerniniMArcangeliAhERG1 potassium channels: novel biomarkers in human solid cancersBioMed Res Int201520159
   Web of Science ®Google Scholar
• PrabhakarUMaedaHJainRChallenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncologyCancer Res20137382412241723423979
   PubMed Web of Science ®Google Scholar
• MaedaHNakamuraHFangJThe EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivoAdv Drug Deliv Rev20131717923088862
   PubMedGoogle Scholar
• LuoGLongJZhangBStroma and pancreatic ductal adenocarcinoma: an interaction loopBiochim Biophys Acta20121826117017822521638
   PubMed Web of Science ®Google Scholar
• GhanehPCostelloENeoptolemosJPBiology and management of pancreatic cancerGut20075681134115217625148
   PubMed Web of Science ®Google Scholar
• ChauhanVPJainRKStrategies for advancing cancer nanomedicineNature Mat20131211958962
   PubMed Web of Science ®Google Scholar
• ProvenzanoPPCuevasCChangAEGoelVKVon HoffDDHingoraniSREnzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinomaCancer Cell201221341842922439937
   PubMed Web of Science ®Google Scholar
• SpadavecchiaJPerumalRBarrasAAmplified plasmonic detection of DNA hybridization using doxorubicin-capped gold particlesAnalyst2014139115716424225546
   PubMed Web of Science ®Google Scholar
• YouJZhangGLiCExceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug releaseACS Nano2010421033104120121065
   PubMed Web of Science ®Google Scholar
• BoisselierEAstrucDGold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicityChem Soc Rev2009381759178219587967
   PubMed Web of Science ®Google Scholar
• PippaNPispasSDemetzosCSivolapenkoGAdvanced nanocarriers for an antitumor peptideJ Nanopart Res2013152062113
   Google Scholar
• HolePSillenceKHannellCInterlaboratory comparison of size measurements on nanoparticles using nanoparticle tracking analysis (NTA)J Nanopart Res20131512112
   Web of Science ®Google Scholar
• LastraioliEPerroneGSetteAhERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinomaBr J Cancer201511261076108725719829
   PubMed Web of Science ®Google Scholar
• BD BiosciencesA guide to absolute counting using the BD Accuri™ C6 flow cytometer Available from: http://static.bdbiosciences.com/documents/accuri/Accuri-TB-Guide-to-Absolute-Counting.pdfAccessed August 2015
   Google Scholar
• KangBAfifiMMAustinLAEl-SayedMAExploiting the nanoparticle plasmon effect: observing drug delivery dynamics in single cells via Raman/fluorescence imaging spectroscopyACS Nano2013787420742723909658
   PubMed Web of Science ®Google Scholar
• JainPKLeeKSEl-SayedIHEl-SayedMACalculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicineJ Phys Chem B2006110147238724816599493
   PubMed Web of Science ®Google Scholar
• LeeKSEl-SayedMADependence of the enhanced optical scattering efficiency relative to that of absorption for gold metal nanorods on aspect ratio, size, end-cap shape, and medium refractive indexJ Phys Chem B200510943203312033816853630
   PubMed Web of Science ®Google Scholar
• LeeKSEl-SayedMAGold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal compositionJ Phys Chem B200611039192201922517004772
   PubMed Web of Science ®Google Scholar
• YguerabideJYguerabideEELight-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applicationsAnal Biochem199826221571769750129
   PubMed Web of Science ®Google Scholar
• AslanKLakowiczJRGeddesCDNanogold plasmon resonance-based glucose sensing. 2. Wavelength-ratiometric resonance light scatteringAnal Chem20057772007201415801731
   PubMed Web of Science ®Google Scholar
• OrendorffCJSauTKMurphyCJShape-dependent plasmon-resonant gold nanoparticlesSmall20062563663917193100
   PubMed Web of Science ®Google Scholar
• HuangXEl-SayedMAGold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapyJ Adv Res2010111328
   Google Scholar
• CarlZeissMicroimagingLLCColocalization analysis in AIM and ZEN Available from: http://www.ecu.edu/cs-dhs/bsomresearchgradstudies/CoreImagingCenter/upload/Colocalization_AIM_ZEN.pdfAccessed August 2015
   Google Scholar
• D’AmicoMGasparoliLArcangeliAPotassium channels: novel emerging biomarkers and targets for therapy in cancerRecent Pat Anticancer Drug Discov20138536522574647
   PubMed Web of Science ®Google Scholar
• LinkSEl-SayedMAOptical properties and ultrafast dynamics of metallic nanocrystalsAnn Rev Phys Chem20035433136612626731
   PubMed Web of Science ®Google Scholar
• JiangW KBRutkaJTChanWCWNanoparticle-mediated cellular response is size-dependentNat Nanotech20083145150
   PubMed Web of Science ®Google Scholar
• OrendorffCJHankinsPLMurphyCJpH-triggered assembly of gold nanorodsLangmuir20052152022202615723505
   PubMed Web of Science ®Google Scholar
• GuYJ CJManCWWongWTChengSHGold-doxorubicin nanoconjugates for overcoming multidrug resistanceNanomedicine20128220421121704592
   PubMed Web of Science ®Google Scholar
• SpadavecchiaJPerumalRBarrasAAmplified plasmonic detection of DNA hybridization using doxorubicin-capped gold particlesAnalyst2014139115716424225546
   PubMed Web of Science ®Google Scholar
• PolitiJDe StefanoLLongobardiSThe amphiphilic hydrophobin Vmh2 plays a key role in one step synthesis of hybrid protein-gold nanoparticlesColloids Surf B Biointerfaces201513621422126402419
   PubMed Web of Science ®Google Scholar
• BagweRPHilliardLRTanWSurface modification of silica nanoparticles to reduce aggregation and nonspecific bindingLangmuir20062294357436216618187
   PubMed Web of Science ®Google Scholar
• LingYHel-NaggarAKPriebeWPerez-SolerRCell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cellsMol Pharmacol19964958328418622633
   PubMed Web of Science ®Google Scholar
• EskelinenELTanakaYSaftigPAt the acidic edge: emerging functions for lysosomal membrane proteinsTrends Cell Biol200313313714512628346
   PubMed Web of Science ®Google Scholar
• FukudaMLysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular traffickingJ Biol Chem19912663221327213301939168
   PubMed Web of Science ®Google Scholar
• MohamedBMVermaNKPrina-MelloAActivation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicityJ Nanobiotechnol2011929
   PubMed Web of Science ®Google Scholar
• KimJSYoonTJYuKNCellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cellsJ Vet Sci20067432132617106221
   PubMed Web of Science ®Google Scholar
• GoldenthalKLPastanIWillinghamMCInitial steps in receptor-mediated endocytosis. The influence of temperature on the shape and distribution of plasma membrane clathrin-coated pits in cultured mammalian cellsExp Cell Res198415225585646144562
   PubMed Web of Science ®Google Scholar
• PearseBMCrowtherRAStructure and assembly of coated vesiclesAnn Rev Biophys Biophys Chem19871649682885011
   PubMedGoogle Scholar
• WilloxAKSahraouiYMRoyleSJNon-specificity of Pitstop 2 in clathrin-mediated endocytosisBiology Open20143532633124705016
   PubMed Web of Science ®Google Scholar
• von KleistLStahlschmidtWBulutHRole of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibitionCell2011146347148421816279
   PubMed Web of Science ®Google Scholar
• RejmanJBragonziAConeseMRole of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexesMol Ther200512346847415963763
   PubMed Web of Science ®Google Scholar
• KlausnerRDDonaldsonJGLippincott-SchwartzJBrefeldin A: insights into the control of membrane traffic and organelle structureJ Cell Biol19921165107110801740466
   PubMed Web of Science ®Google Scholar
• PelhamHRMultiple targets for brefeldin ACell19916734494511934055
   PubMed Web of Science ®Google Scholar
• PapakonstantiEAStournarasCCell responses regulated by early reorganization of actin cytoskeletonFEBS Lett2008582142120212718325339
   PubMed Web of Science ®Google Scholar
• BarenholzYDoxil® – the first FDA-approved nano-drug: lessons learnedJ Cont Release20121602117134
   PubMed Web of Science ®Google Scholar
• FerlayJSteliarova-FoucherELortet-TieulentJCancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012Eur J Cancer20134961374140323485231
   PubMed Web of Science ®Google Scholar
• HaqqJHowellsLMGarceaGMetcalfeMSStewardWPDennisonARPancreatic stellate cells and pancreas cancer: current perspectives and future strategiesEur J Cancer201450152570258225091797
   PubMed Web of Science ®Google Scholar
• SetteA SJLandoulsiJCasaleSHayeBCrocianiOArcangeliADevelopment of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cellsJ Nanopart Res201315211124348091
   PubMed Web of Science ®Google Scholar
• GasparoliLD’AmicoMMasselliMNew pyrimido-indole compound CD-160130 preferentially inhibits the KV11.1B isoform and produces antileukemic effects without cardiotoxicityMol Pharmacol201587218319625411366
   PubMed Web of Science ®Google Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov20109861562720616808
   PubMed Web of Science ®Google Scholar
• EtrychTSubrVLagaRRihovaBUlbrichKPolymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumoursEur J Pharm Sci20145811224632485
   PubMed Web of Science ®Google Scholar
• OhKTYinHLeeESBaeYHPolymeric nanovehicles for anticancer drugs with triggering release mechanismsJ Mater Chem2007173839874001
   Web of Science ®Google Scholar
• PecharMUlbrichKSubrVSeymourLWSchachtEHPoly(ethylene glycol) multiblock copolymer as a carrier of anti-cancer drug doxorubicinBioconjug Chem200011213113910725088
   PubMed Web of Science ®Google Scholar
• UlbrichKSubrVStrohalmJPlocovaDJelinkovaMRihovaBPolymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisationJ Cont Release2000641–36379
   Web of Science ®Google Scholar
• KhullarPMahalASinghVBanipalTSKaurGBakshiMSHow PEO-PPO-PEO triblock polymer micelles control the synthesis of gold nanoparticles: temperature and hHydrophobic effectsLangmuir20102613113631137120369849
   PubMed Web of Science ®Google Scholar
• DawidczykCMKimCParkJHState-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicinesJ Cont Release2014187133144
   PubMed Web of Science ®Google Scholar
• ZhangGYangZLuWInfluence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted miceBiomaterials200930101928193619131103
   PubMed Web of Science ®Google Scholar
• DanielMC ADGold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnologyChem Rev2004104129334614719978
   PubMed Web of Science ®Google Scholar
• VandenbergJIPerryMDPerrinMJMannSAKeYHillAPhERG K(+) channels: structure, function, and clinical significancePhysiol Rev20129231393147822988594
   PubMed Web of Science ®Google Scholar
• ShannonRRevised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesActa Cryst1976A325751767
   Google Scholar
• ByrneJDBetancourtTBrannon-PeppasLActive targeting schemes for nanoparticle systems in cancer therapeuticsAdv Drug Deliv Rev200860151615162618840489
   PubMed Web of Science ®Google Scholar
• WolframJYangYShenJThe nano-plasma interface: implications of the protein coronaColloids Surf B Biointerfaces2014124172424656615
   PubMed Web of Science ®Google Scholar
• EatonMALevyLFontaineOMDelivering nanomedicines to patients: a practical guideNanomedicine201511498399225724929
   PubMed Web of Science ®Google Scholar
• KundraRKornfeldSAsparagine-linked oligosaccharides protect Lamp-1 and Lamp-2 from intracellular proteolysisJ Biol Chem199927443310393104610521503
   PubMed Web of Science ®Google Scholar
• BeddoesCMCaseCPBriscoeWHUnderstanding nanoparticle cellular entry: a physicochemical perspectiveAdv Colloid Interface Sci2015218486825708746
   PubMed Web of Science ®Google Scholar
• SternSTAdiseshaiahPPCristRMAutophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicityPart Fibre Toxicol201292022697169
   PubMed Web of Science ®Google Scholar
• SchutzeSTchikovVSchneider-BrachertWRegulation of TNFR1 and CD95 signalling by receptor compartmentalizationNat Rev Mol Cell Biol20089865566218545270
   PubMed Web of Science ®Google Scholar
• McMahonHTBoucrotEMolecular mechanism and physiological functions of clathrin-mediated endocytosisNat Rev Mol Cell Biol201112851753321779028
   PubMed Web of Science ®Google Scholar
• FickerEDennisATWangLBrownAMRole of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERGCirc Res20039212e87e10012775586
   PubMed Web of Science ®Google Scholar
• GongQKeeneyDRMolinariMZhouZDegradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathwayJ Biol Chem200528019194191942515760896
   PubMed Web of Science ®Google Scholar
• GuoJMassaeliHXuJExtracellular K+ concentration controls cell surface density of IKr in rabbit hearts and of the HERG channel in human cell linesJ Clin Invest200911992745275719726881
   PubMed Web of Science ®Google Scholar